Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis

被引：56

作者：

Bochtler, Tilmann ^{[1
]}

Hegenbart, Ute ^{[1
]}

Heiss, Christiane ^{[2
,4
]}

Benner, Axel ^{[2
]}

Cremer, Friedrich ^{[1
]}

Volkmann, Martin ^{[3
]}

Ludwig, Jochen ^{[3
]}

Perz, Jolanta B. ^{[1
]}

Ho, Anthony D. ^{[1
]}

Goldschmidt, Hartmut ^{[1
]}

Schonland, Stefan O. ^{[1
]}

机构：

[1] Heidelberg Univ, Dept Internal Med, Amyloidosis Clin, Div Hematol Oncol, Heidelberg, Germany

[2] German Canc Res Ctr, Div Biostat C060, Heidelberg, Germany

[3] Heidelberg Univ, Dept Internal Med & Clin Chem 1, Heidelberg, Germany

[4] Heidelberg Univ, Dept Internal Med, Div Hematol Oncol, Heidelberg, Germany

来源：

HAEMATOLOGICA | 2008年 / 93卷 / 03期

关键词：

serum-free light chain test; AL amyloidosis; Karnofsky index; bone marrow plasmocytosis; heart disease;

D O I：

10.3324/haematol.11687

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We evaluated the Serum Free Light Chain (FLC) test in a series of 133 untreated patients with systemic AL amyloidosis. The FLC test detected the monoclonal gammopathy in 87% compared with 92% for immunofixation of serum and urine in combination. However, both tests proved complementary. The FLC test was also a valuable tool in patients with advanced renal failure in spite of uninvolved light chain retention. Higher FLC levels were associated with higher bone marrow plasmocytosis, poorer Karnofsky index and heart involvement, and therefore reflected disease severity.

引用

页码：459 / 462

页数：4

共 18 条

[1] Quantitative analysis of serum free light chains - A new marker for the diagnostic evaluation of primary systemic amyloidosis [J].

Abraham, RS ;

Katzmann, JA ;

Clark, RJ ;

Bradwell, AR ;

Kyle, RA ;

Gertz, MA .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 119 (02) :274-278

[2] Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis [J].

Akar, H ;

Seldin, DC ;

Magnani, B ;

O'Hara, C ;

Berk, JL ;

Schoonmaker, C ;

Cabral, H ;

Dember, LM ;

Sanchorawala, V ;

Connors, LH ;

Falk, RH ;

Skinner, M .

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2005, 12 (04) :210-215

[3]

Bradwell AR, 2001, CLIN CHEM, V47, P673

[4] Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation [J].

Dispenzieri, A ;

Lacy, MQ ;

Katzmann, JA ;

Rajkumar, SV ;

Abraham, RS ;

Hayman, SR ;

Kumar, SK ;

Clark, R ;

Kyle, RA ;

Litzow, MR ;

Inwards, DJ ;

Ansell, SM ;

Micallef, IM ;

Porrata, LF ;

Elliott, MA ;

Johnston, PB ;

Greipp, PR ;

Witzig, TE ;

Zeldenrust, SR ;

Russell, SJ ;

Gastineau, D ;

Gertz, MA .

BLOOD, 2006, 107 (08) :3378-3383

[5]

DURIE BGM, 1986, SEMIN ONCOL, V13, P300

[6] Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis [J].

Gertz, MA ;

Comenzo, R ;

Falk, RH ;

Fermand, JP ;

Hazenberg, BP ;

Hawkins, PN ;

Merlini, G ;

Moreau, P ;

Ronco, P ;

Sanchorawala, V ;

Sezer, O ;

Solomon, A ;

Grateau, G .

AMERICAN JOURNAL OF HEMATOLOGY, 2005, 79 (04) :319-328

[7]

HOLM S, 1979, SCAND J STAT, V6, P65

[8] Diagnostic performance of quantitative κ and λ free light chain assays in clinical practice [J].

Katzmann, JA ;

Abraham, RS ;

Dispenzieri, A ;

Lust, JA ;

Kyle, RA .

CLINICAL CHEMISTRY, 2005, 51 (05) :878-881

[9]

Katzmann JA, 2002, CLIN CHEM, V48, P1437

[10] Immunohistochemical classification of amyloid in surgical pathology revisited [J].

Kebbel, Anja ;

Roecken, Christoph .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (06) :673-683

← 1 2 →